新生儿生长受限德尔菲共识定义对识别新生儿疾病的效度
该研究基于2016年和2021年法国全国围产调查,纳入23,897例活产单胎,评估德尔菲共识新生儿生长受限定义的患病率及其与新生儿疾病复合终点的关联,并与基于出生体重百分位的小于胎龄儿定义比较。德尔菲定义下生长受限患病率为4.9%(95%CI 4.6-5.2),其中29.7%发生疾病,校正相对危险度为2.5(95%CI 2.2-2.7)。校正模型同时纳入德尔菲定义和出生体重百分位分组后,第3至第4百分位和第5至第9百分位的疾病风险仍升高(校正RR均为1.4),而德尔菲定义不再显著(校正RR 0.9,95%CI 0.7-1.2)。结论认为德尔菲共识定义并未比基于出生体重百分位的定义识别出更多有病新生儿,提示共识研究结果在临床采用前需先评估。
要点
- 德尔菲共识生长受限定义为出生体重低于第3百分位,或满足以下至少3项:出生体重、头围或身长低于第10百分位,产前诊断生长受限,或母亲高血压。
- 德尔菲定义下生长受限患病率为4.9%(95%CI 4.6-5.2),其中29.7%发生新生儿疾病,校正RR 2.5(95%CI 2.2-2.7)。
- 与出生体重≥第10百分位相比,出生体重低于第3百分位者疾病校正RR 3.3(95%CI 3.0-3.7),第3至第4百分位者RR 1.4(95%CI 1.1-1.7),第5至第9百分位者RR 1.4(95%CI 1.2-1.6)。
- 校正模型同时纳入两种定义并排除出生体重低于第3百分位后,第3至第4百分位(校正RR 1.4,95%CI 1.1-1.7)和第5至第9百分位(校正RR 1.4,95%CI 1.2-1.6)疾病风险仍升高,德尔菲定义不再显著(校正RR 0.9,95%CI 0.7-1.2)。
- 足月与早产新生儿中观察到相似模式。
适用人群与场景
- 2016年和2021年法国全国围产调查中所有妊娠≥22周和/或出生体重≥500 g的出生,覆盖法国所有产科单位为期1周的数据。
- 研究人群为23,897例活产单胎。
- 数据来自医疗记录和产后母亲访谈。
诊断标准与关键阈值
- 德尔菲共识新生儿生长受限定义:出生体重低于第3百分位,或满足以下至少3项:出生体重、头围或身长低于第10百分位,产前诊断生长受限,或母亲高血压。
- 小于胎龄儿按出生体重百分位阈值定义:低于第3百分位、第3至第4百分位、第5至第9百分位,参照组为出生体重≥第10百分位。
研究设计与关键结果
- 研究类型:基于2016年和2021年法国全国围产调查数据的分析,纳入23,897例活产单胎。
- 德尔菲定义下生长受限患病率为4.9%(95%CI 4.6-5.2),其中29.7%发生新生儿疾病,校正RR 2.5(95%CI 2.2-2.7)。
- 与出生体重≥第10百分位相比,出生体重低于第3百分位者疾病校正RR 3.3(95%CI 3.0-3.7),第3至第4百分位者RR 1.4(95%CI 1.1-1.7),第5至第9百分位者RR 1.4(95%CI 1.2-1.6)。
- 校正模型同时纳入德尔菲定义和出生体重百分位分组并排除出生体重低于第3百分位后,第3至第4百分位疾病校正RR 1.4(95%CI 1.1-1.7),第5至第9百分位校正RR 1.4(95%CI 1.2-1.6),德尔菲定义校正RR 0.9(95%CI 0.7-1.2)。
- 足月与早产新生儿中观察到相似模式。
- 新生儿疾病复合终点定义:5分钟Apgar评分<7、脐动脉pH<7.10、复苏和/或新生儿入院。
- 相对危险度校正了母亲特征(年龄、产次、体质指数、吸烟、教育水平、既存高血压和糖尿病、研究年份),随后校正了共识定义和出生体重百分位分组;缺失数据采用链式方程多重插补。
证据类型、等级与局限
- 证据类型:基于法国全国围产调查数据的分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,这些发现说明在临床实践采用德尔菲共识研究结果之前评估其效度的重要性。
- 德尔菲共识定义并未比基于出生体重百分位的定义识别出更多发生疾病的新生儿。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Small for gestational age is defined as a birthweight below a birthweight percentile threshold, usually the 10th percentile, with the third or fifth percentile used to identify severe small for gestational age. Small for gestational age is used as a proxy for growth restriction in the newborn, but small-for-gestational-age newborns can be physiologically small and healthy. In addition, this definition excludes growth-restricted newborns who have weights more than the 10th percentile. To address these limits, a Delphi study developed a new consensus definition of growth restriction in newborns on the basis of neonatal anthropometric and clinical parameters, but it has not been evaluated.
OBJECTIVE: To assess the prevalence of growth restriction in the newborn according to the Delphi consensus definition and to investigate associated morbidity risks compared with definitions of Small for gestational age using birthweight percentile thresholds.
STUDY DESIGN: Data come from the 2016 and 2021 French National Perinatal Surveys, which include all births ≥22 weeks and/or with birthweights ≥500 g in all maternity units in France over 1 week. Data are collected from medical records and interviews with mothers after the delivery. The study population included 23,897 liveborn singleton births. The Delphi consensus definition of growth restriction was birthweight less than third percentile or at least 3 of the following criteria: birthweight, head circumference or length <10th percentile, antenatal diagnosis of growth restriction, or maternal hypertension. A composite of neonatal morbidity at birth, defined as 5-minute Apgar score <7, cord arterial pH <7.10, resuscitation and/or neonatal admission, was compared using the Delphi definition and usual birthweight percentile thresholds for defining small for gestational age using the following birthweight percentile groups: less than a third, third to fourth, and fifth to ninth percentiles. Relative risks were adjusted for maternal characteristics (age, parity, body mass index, smoking, educational level, preexisting hypertension and diabetes, and study year) and then for the consensus definition and birthweight percentile groups. Multiple imputation by chained equations was used to impute missing data. Analyses were carried out in the overall sample and among term and preterm newborns separately.
RESULTS: We identified that 4.9% (95% confidence intervals, 4.6-5.2) of newborns had growth restriction. Of these infants, 29.7% experienced morbidity, yielding an adjusted relative risk of 2.5 (95% confidence intervals, 2.2-2.7) compared with newborns without growth restriction. Compared with birthweight ≥10th percentile, morbidity risks were higher for low birthweight percentiles (less than third percentile: adjusted relative risk, 3.3 [95% confidence intervals, 3.0-3.7]; third to fourth percentile: relative risk, 1.4 [95% confidence intervals, 1.1-1.7]; fifth to ninth percentile: relative risk, 1.4 [95% confidence intervals, 1.2-1.6]). In adjusted models including the definition of growth restriction and birthweight percentile groups and excluding birthweights less than third percentile, which are included in both definitions, morbidity risks remained higher for birthweights at the third to fourth percentile (adjusted relative risk, 1.4 [95% confidence intervals, 1.1-1.7]) and fifth to ninth percentile (adjusted relative risk, 1.4 [95% confidence intervals, 1.2-1.6]), but not for the Delphi definition of growth restriction (adjusted relative risk, 0.9 [95% confidence intervals, 0.7-1.2]). Similar patterns were found for term and preterm newborns.
CONCLUSION: The Delphi consensus definition of growth restriction did not identify more newborns with morbidity than definitions of small for gestational age on the basis of birthweight percentiles. These findings illustrate the importance of evaluating the results of Delphi consensus studies before their adoption in clinical practice.
参考来源
- Monier I, Ego A, Hocquette A, et al. Validity of a Delphi consensus definition of growth restriction in the newborn for identifying neonatal morbidity. Am J Obstet Gynecol. 2024. PMID: 38697341. doi:10.1016/j.ajog.2024.04.033
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。